When a patient presents with chest pain, follow this doctor’s guidelines to quickly reach an accurate diagnosis and initiate life-saving treatment. For some time, cardiologists have called MIs and ...

The 2011 focused update was published online March 28, 2011, ahead of print in the Journal of the American College of Cardiology and Circulation. The writing committee, led by R. Scott Wright, MD, of ...

Characteristics of STEMI Reperfusion Systems Identified Aspirin is still the first line of therapy for patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and ticagrelor ...

This guideline covers the early and longer-term (rehabilitation) management of acute coronary syndromes. These include ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation ...

Bleeding rates are steadily dropping after both elective and emergent percutaneous coronary intervention (PCI), according to registry data published in the May 22, 2012, issue of the Journal of the ...

Final draft guidance published today (16 September) by NICE confirms its previous positive draft recommendation for ticagrelor (Brilique, Astrazeneca). The draft guidance recommends ticagrelor within ...

In draft guidance published today for consultation, NICE has recommended rivaroxaban (Xarelto, Bayer Healthcare) as an option for preventing blood clots in people who have had a heart attack as a ...

Since the start of 2011, the active ingredient ticagrelor can be prescribed in Germany in addition to acetylsalicylic acid to avoid blood clots in patients with acute ischaemia of the cardiac muscle.

Oral anti-platelet therapy Effient (prasugrel) has been added to the updated clinical practice guidelines as a class I recommended treatment option for patients undergoing Percutaneous Coronary ...

(1) How was this issue identified? Starting in quarter 1 2007, we noticed the high rate of excess dosing for heparin on our ACTION site reports compared to national rates. (2) What did you do to ...

Individuals with diabetes and acute coronary syndromes such as a heart attack or unstable angina have an increased risk of death at 30 days and one year after ACS, compared with ACS patients without ...

This guideline covers the early and longer-term (rehabilitation) management of acute coronary syndromes. These include ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation ...